2009 ASO CVSCaremark Principal Life Prior Authorization and
Des Moines, IA 50392-0002 Insurance Company Dispensing Limitation List The following drugs have a Dispensing Limitation (quantity limit per 30 days unless otherwise specified) Prescription Drug Quantity Limits Comments
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Limitation applies to drugs either singularly or in combination
Prescription Drug Quantity Limits Comments Prior Authorization Drugs Acne Agents for individuals 31 years of age and older Actinic Kerasotes (Solaraze) Antihyperglycemic (Symlin, Byetta) for individuals 18 years of age and older Benign Prostatic Hypertrophy (Avodart, Proscar, finasteride) Blood Modifiers (Aranesp, Epogen, Leukine, Neulasta, Neupogen, Procrit) – Specialty Rx Benefit Crohne’s Disease (Cimzia) – Speciality Rx Benefit Erectile Dysfunction (Viagra, Cialis, Levitra) for males through the age of 49 years Growth Hormones - Specialty Rx Benefit Hepatitis C (Infergen, Intron A, Pegasys, Peg-Intron, Redipen, Rebetron, Roferon-A) - Specialty Rx Benefit Irritable Bowel Syndrome (Lotronex, Zelnorm) IVIG Medications – Specialty Rx Benefit Lupron, Lupron Depot Ped, leuprolide acetate - for diagnosis other than infertility - Specialty Rx Benefit Miscellaneous (Actimmune, Alferon N, Botox, Forteo, Myobloc, Prialt, Progesterone in Oil, Synagis, Viadur, Xolair) – Specialty Rx Benefit Multiple Sclerosis (Avonex, Betaseron, Copaxone, Novantrone, Rebif, Tysabri, mitoxantrone) – Specialty Rx Benefit Metabolic Modifier-(Kuvan)-Specialty Rx Benefit Narcolepsy (Provigil) Narcotic Analgesics (Actiq, fentanyl citrate, Fentora) Oncology (Arimidex, Aromasin, Femara, Gleevac, Iressa, Nexavar, Revlimid, Sprycel, Sutent, Tarceva, Temordar, Tykerb, Xeloda, Zolinza) Oncology (Rituxan, Tasigna, Trelstar) – Specialty Rx Benefit Osteo-Arthritis (Euflexxa, Hyalgan, Orthovisc, Supartz, Synvisc) – Specialty Rx Benefit Other (Anabolic Steroids (oral only), Progesterone, Micronized (Crinone and Prochieve), Testosterone (Androgel) Psoriasis (Amevive, Raptiva) – Specialty Rx Benefit Pulmonary Arterial Hypertension (Revatio all Genders, Viagra Females only) Rheumatoid Arthritis (Arava, leflunomide) Rheumatology (Enbrel, Humira, Kineret, Orencia, Remicade) – Specialty Rx Benefit Secondary Hyperparathyroidism and Hypercalcemia (Sensipar) Transplant/Anti-Rejection (Cellcept, Myfortic) Additional drugs may be added to the prior authorization or quantity limit list throughout the year. Your specific benefit design may not cover certain drugs, even though they appear on this list. This document is a summary reference and may not necessarily reflect all coverage and exclusions of the plan benefit system. Please contact your account team for any questions. Prior Authorization Process For the medications on this form that indicate a prior authorization is required, please follow the process below. 1. Bring your prescription to a pharmacist. 2. If not approved, the pharmacist will receive a prompt stating that the physician must contact or call 888-413-2723 for
3. The pharmacist should advise the member to have their physician call the number given above. 4. This means that either your doctor will have to call the number or FAX a letter of medical necessity to CVSCaremark.
Physician prior authorization number 888-413-2723
Physician prior authorization FAX number 888-836-0730
5. CVSCaremark will evaluate the information received based on our internally developed clinical criteria. The decision
will be an approval, denial, or review for more information.
Approval After a claim is approved, an override is applied so that the claim will process electronically at the pharmacy and a letter will be sent to the member and the physician indicating the approval and the time period it is valid for. Denial If the medication is denied, then a letter is sent to both the physician and the member. The denial letter will outline directions on how to appeal the decision. Missing Information If more information is required, the physician’s office will be contacted. Once the physician’s office provides CVSCaremark with the required information then a review will be completed within 24 – 48 hours.
INJECTABLE METHOTREXATE Methotrexate is an anti-neoplastic or chemotherapeutic agent used primarily in the treatment of cancer. Methotrexate has immunosuppressive properties and is often used to treat a number on non-cancer related disorders. It is important to note that regardless of the indication for Methotrexate, it is still considered to be a chemotherapeutic agent, and must be regarde
A Case of Herpes ZosterNicholas Nossaman, MD, DHt59 y/o African-American college professor with ulcerative colitis since1983, for which I was able to provide only very little help with homeopathyand for which he takes Azulfidine. He also has sclerosing cholangitis (forwhich he takes Actigall) and interstitial lung disease, both of which havebeen improved with homeopathy. He presented on 12/19/05